Alto NeuroscienceANRO stock score: 36/100

$26.51 · +2.32% · Scored Nov 19, 2026

Technical
53
Fundamental
32
News
57

The reading

Alto Neuroscience (ANRO) scores 36 out of 100, which reads bearish, higher than 13% of Healthcare stocks and 14% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 32, technicals 53.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Quality (Annual) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 53 and contrarian oscillators 49.

News sentiment is neutral at 57; it is shown, not counted in the composite.

Since Aug 23, 2026 the composite has ranged from 34 to 52, and it is down 15 points over the period.

About Alto Neuroscience

Alto Neuroscience (ANRO) is a clinical-stage biopharmaceutical company developing treatments for mental health conditions using a precision psychiatry approach. It uses biomarkers from EEG brain activity, cognitive tests, wearable devices and other data to identify which patients are most likely to respond to each drug. Its pipeline includes ALTO-100, being studied in bipolar depression, and ALTO-300, being studied as an add-on treatment for major depressive disorder in patients selected by an EEG biomarker. It also has ALTO-101 for cognitive impairment associated with schizophrenia, which has received Fast Track designation, ALTO-203 for depression with prominent anhedonia, and ALTO-207, a combination therapy for treatment-resistant depression. The company has no product revenue and funds its research mainly with cash from stock sales.

Alto competes with larger drugmakers that sell or are developing treatments for depression, bipolar disorder and schizophrenia, such as Johnson & Johnson, AbbVie and Bristol Myers Squibb, along with other biotech companies working in neuropsychiatry. Its edge rests on a biomarker platform and data set that it uses to match patients to drugs, along with a pipeline of several candidates. Investors who follow ANRO stock tend to watch data readouts from its mid-stage trials and whether biomarker-selected patients respond better than others. Plans for late-stage development are closely followed. Cash runway, potential partnerships and share dilution are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward ANRO’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

32

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

  • Absolute profitability: whether the company is profitable, its net margin against the sector range, and how consistently it has been profitable over three years.

  • Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.

  • Return on Assets (ROA) shows how efficiently a company uses its assets to generate profit.

27 weighted scorers; 12 had no data today and are left out rather than counted as zero.

Technical · daily

53

Pulling it up

Holding it back

  • Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • Simple Moving Average (10-period) smooths price action over 10 periods.

  • SPY SMA 20 measures the S&P 500 (SPY) position relative to its 20-period moving average.

61 weighted scorers; 4 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
57

Technical score by timeframe

ChartScoreWeight
Hourly451
Daily533
Weekly562

Composite score, last 90 days

05010036Aug 23, 2026Nov 19, 2026Aug 23, 2026: 51Aug 24, 2026: 52Aug 25, 2026: 51Aug 26, 2026: 51Aug 27, 2026: 51Aug 28, 2026: 49Aug 29, 2026: 49Aug 30, 2026: 49Aug 31, 2026: 50Sep 1, 2026: 50Sep 2, 2026: 51Sep 4, 2026: 51Sep 5, 2026: 50Sep 6, 2026: 50Sep 7, 2026: 50Sep 8, 2026: 50Sep 9, 2026: 48Sep 10, 2026: 47Sep 11, 2026: 48Sep 12, 2026: 48Sep 13, 2026: 48Sep 14, 2026: 48Sep 15, 2026: 46Sep 16, 2026: 46Sep 17, 2026: 48Sep 18, 2026: 47Sep 19, 2026: 47Sep 20, 2026: 47Sep 21, 2026: 47Sep 22, 2026: 48Sep 23, 2026: 46Sep 24, 2026: 45Sep 25, 2026: 44Sep 26, 2026: 44Sep 27, 2026: 44Sep 28, 2026: 44Sep 29, 2026: 45Sep 30, 2026: 43Oct 1, 2026: 43Oct 2, 2026: 44Oct 3, 2026: 44Oct 4, 2026: 44Oct 5, 2026: 43Oct 6, 2026: 43Oct 7, 2026: 43Oct 8, 2026: 44Oct 9, 2026: 44Oct 10, 2026: 44Oct 11, 2026: 44Oct 12, 2026: 44Oct 13, 2026: 41Oct 14, 2026: 42Oct 15, 2026: 42Oct 16, 2026: 41Oct 17, 2026: 41Oct 18, 2026: 41Oct 19, 2026: 42Oct 20, 2026: 45Oct 21, 2026: 43Oct 22, 2026: 41Oct 23, 2026: 41Oct 24, 2026: 41Oct 25, 2026: 41Oct 26, 2026: 41Oct 27, 2026: 44Oct 28, 2026: 43Oct 29, 2026: 45Oct 30, 2026: 42Nov 1, 2026: 42Nov 2, 2026: 43Nov 3, 2026: 44Nov 4, 2026: 44Nov 5, 2026: 40Nov 6, 2026: 44Nov 7, 2026: 44Nov 10, 2026: 49Nov 11, 2026: 51Nov 12, 2026: 36Nov 13, 2026: 38Nov 14, 2026: 38Nov 15, 2026: 37Nov 16, 2026: 37Nov 17, 2026: 34Nov 18, 2026: 36Nov 19, 2026: 36
Show the daily numbers
DateComposite
Nov 19, 202636
Nov 18, 202636
Nov 17, 202634
Nov 16, 202637
Nov 15, 202637
Nov 14, 202638
Nov 13, 202638
Nov 12, 202636
Nov 11, 202651
Nov 10, 202649
Nov 7, 202644
Nov 6, 202644
Nov 5, 202640
Nov 4, 202644
Nov 3, 202644
Nov 2, 202643
Nov 1, 202642
Oct 30, 202642
Oct 29, 202645
Oct 28, 202643
Oct 27, 202644
Oct 26, 202641
Oct 25, 202641
Oct 24, 202641
Oct 23, 202641
Oct 22, 202641
Oct 21, 202643
Oct 20, 202645
Oct 19, 202642
Oct 18, 202641
Oct 17, 202641
Oct 16, 202641
Oct 15, 202642
Oct 14, 202642
Oct 13, 202641
Oct 12, 202644
Oct 11, 202644
Oct 10, 202644
Oct 9, 202644
Oct 8, 202644
Oct 7, 202643
Oct 6, 202643
Oct 5, 202643
Oct 4, 202644
Oct 3, 202644
Oct 2, 202644
Oct 1, 202643
Sep 30, 202643
Sep 29, 202645
Sep 28, 202644
Sep 27, 202644
Sep 26, 202644
Sep 25, 202644
Sep 24, 202645
Sep 23, 202646
Sep 22, 202648
Sep 21, 202647
Sep 20, 202647
Sep 19, 202647
Sep 18, 202647
Sep 17, 202648
Sep 16, 202646
Sep 15, 202646
Sep 14, 202648
Sep 13, 202648
Sep 12, 202648
Sep 11, 202648
Sep 10, 202647
Sep 9, 202648
Sep 8, 202650
Sep 7, 202650
Sep 6, 202650
Sep 5, 202650
Sep 4, 202651
Sep 2, 202651
Sep 1, 202650
Aug 31, 202650
Aug 30, 202649
Aug 29, 202649
Aug 28, 202649
Aug 27, 202651
Aug 26, 202651
Aug 25, 202651
Aug 24, 202652
Aug 23, 202651

Key facts

Market cap
$1.1B
Sector
Healthcare
Industry
Biotechnology
Beta
1.45
Risk grade (1–10)
10
Next earnings
Nov 10, 2026

Questions

What is ANRO's stock rating today?

ANRO scores 36/100 (Bearish) as of Nov 19, 2026: technical 53, fundamental 32, and news sentiment 57, which is shown but not counted. Scores are recomputed every night.

What does Alto Neuroscience do?

Alto Neuroscience (ANRO) is a clinical-stage biopharmaceutical company developing treatments for mental health conditions using a precision psychiatry approach. It uses biomarkers from EEG brain activity, cognitive tests, wearable devices and other data to identify which patients are most likely to respond to each drug.

Is ANRO stock a buy?

The score is not a buy or sell recommendation. A 36 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the ANRO score calculated?

88 weighted scorers feed it today: 27 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 3 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

ANRO stock score

HTML

<a href="https://stocksscores.com/stocks/anro/"><img src="https://stocksscores.com/stocks/anro/badge.svg" alt="ANRO stock score" height="20"></a>

Markdown

[![ANRO stock score](https://stocksscores.com/stocks/anro/badge.svg)](https://stocksscores.com/stocks/anro/)